QUIAPEG Trademark

Trademark Overview


On Monday, September 2, 2019, a trademark application was filed for QUIAPEG with the United States Patent and Trademark Office. The USPTO has given the QUIAPEG trademark a serial number of 79271613. The federal status of this trademark filing is REGISTERED as of Tuesday, November 3, 2020. This trademark is owned by QuiaPEG Pharmaceuticals AB. The QUIAPEG trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease derived from PEGylation technologies; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; pharmaceutical, medical and veterinary substances

Scientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations, reagents and substances, and of diagnostic preparations, reagents and substances derived from PEGylation technologies; PEGylation pharmaceuticals research services

Reagents for scientific and research use, Diagnostic preparations for scientific or research use, namely, reagents for use with a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers
quiapeg

General Information


Serial Number79271613
Word MarkQUIAPEG
Filing DateMonday, September 2, 2019
Status700 - REGISTERED
Status DateTuesday, November 3, 2020
Registration Number6187216
Registration DateTuesday, November 3, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2020

Trademark Statements


Goods and ServicesPharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease derived from PEGylation technologies; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; pharmaceutical, medical and veterinary substances
Goods and ServicesScientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations, reagents and substances, and of diagnostic preparations, reagents and substances derived from PEGylation technologies; PEGylation pharmaceuticals research services
Translation of Words in MarkThe wording "QUIAPEG" has no meaning in a foreign language.
Goods and ServicesReagents for scientific and research use, Diagnostic preparations for scientific or research use, namely, reagents for use with a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, November 15, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 15, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQuiaPEG Pharmaceuticals AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSE

Party NameQuiaPEG Pharmaceuticals AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSE

Party NameQuiaPEG Pharmaceuticals AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSE

Trademark Events


Event DateEvent Description
Thursday, November 14, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 19, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, December 4, 2019ASSIGNED TO EXAMINER
Wednesday, December 4, 2019NON-FINAL ACTION WRITTEN
Thursday, December 5, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 5, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, January 21, 2020NON-FINAL ACTION WRITTEN
Wednesday, January 22, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, February 15, 2020REFUSAL PROCESSED BY MPU
Sunday, February 16, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, March 7, 2020REFUSAL PROCESSED BY IB
Thursday, May 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 28, 2020ASSIGNED TO LIE
Thursday, May 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 19, 2020LIMITATION OF GOODS RECEIVED FROM IB
Thursday, July 9, 2020LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Monday, July 13, 2020ATTORNEY REVIEW COMPLETED
Monday, July 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 18, 2020PUBLISHED FOR OPPOSITION
Tuesday, August 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, February 3, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, February 12, 2021FINAL DISPOSITION PROCESSED
Friday, February 12, 2021FINAL DISPOSITION NOTICE SENT TO IB
Sunday, March 7, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, November 3, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED